Levodopa



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Parkinson's Disease 57.1%
Diabetes Mellitus 28.6%
Drug Effect Decreased 14.3%
Therapeutic Response Increased 33.3%
Dyskinesia 16.7%
Oromandibular Dystonia 16.7%
Osteomalacia 16.7%
Pathological Gambling 16.7%
Secondary
Parkinson's Disease 66.3%
Product Used For Unknown Indication 11.0%
Psychotic Disorder 5.4%
Depression 2.5%
Parkinsonism 2.1%
On And Off Phenomenon 2.0%
Dyskinesia 1.4%
Drug Effect Decreased 1.2%
Cardiac Failure Chronic 1.1%
Drug Use For Unknown Indication 1.1%
Dystonia 0.9%
Rapid Eye Movements Sleep Abnormal 0.8%
Anxiety 0.7%
Restless Legs Syndrome 0.7%
Back Pain 0.5%
Paranoia 0.5%
Completed Suicide 0.5%
Hypertonic Bladder 0.5%
Delirium 0.4%
Essential Tremor 0.4%
Pathological Gambling 16.3%
On And Off Phenomenon 7.5%
Stereotypy 6.8%
Psychotic Disorder 6.1%
Tremor 6.1%
Dopamine Dysregulation Syndrome 5.4%
Drug Abuse 5.4%
Suicide Attempt 5.4%
Drug Ineffective 4.8%
Hypersexuality 4.8%
Delirium 4.1%
Paranoia 4.1%
Syncope 3.4%
Vomiting 3.4%
Delusion 2.7%
Impaired Driving Ability 2.7%
Neuroleptic Malignant Syndrome 2.7%
No Adverse Event 2.7%
Oedema Peripheral 2.7%
Paradoxical Drug Reaction 2.7%
Concomitant
Parkinson's Disease 42.1%
Product Used For Unknown Indication 19.7%
Drug Use For Unknown Indication 9.2%
Hypertension 4.7%
Depression 3.9%
Restless Legs Syndrome 2.4%
Multiple Sclerosis 1.9%
Parkinsonism 1.9%
Ill-defined Disorder 1.6%
Type 2 Diabetes Mellitus 1.5%
Diabetes Mellitus 1.4%
Epilepsy 1.3%
Pain 1.3%
B-cell Lymphoma 1.2%
Osteoporosis 1.2%
Dementia 1.0%
Drug Effect Decreased 1.0%
Renal Cell Carcinoma 1.0%
Rheumatoid Arthritis 0.9%
Multiple Myeloma 0.8%
Somnolence 11.4%
Parkinson's Disease 9.5%
Tremor 7.6%
Death 6.8%
Wrong Drug Administered 6.8%
Vomiting 5.7%
Myocardial Infarction 5.3%
Hallucination 4.5%
Serotonin Syndrome 4.2%
Urinary Tract Infection 4.2%
Weight Decreased 4.2%
Dyskinesia 3.8%
Rhabdomyolysis 3.8%
White Blood Cell Count Decreased 3.8%
Drug Ineffective 3.4%
Loss Of Consciousness 3.4%
Pneumonia 3.4%
Psychotic Disorder 3.0%
Confusional State 2.7%
Delusion 2.7%
Interacting
Parkinson's Disease 30.8%
Epilepsy 17.6%
Drug Effect Decreased 11.9%
Hiv Infection 10.1%
Dementia With Lewy Bodies 5.7%
Tuberculous Pleurisy 5.7%
Diabetes Mellitus 2.5%
Lipids Increased 2.5%
Constipation 1.9%
Gastritis 1.9%
Analgesic Therapy 1.3%
Diabetic Neuropathy 1.3%
Drug Use For Unknown Indication 1.3%
Gastrointestinal Disorder 1.3%
Rheumatic Disorder 1.3%
Delirium 0.6%
Dementia 0.6%
Major Depression 0.6%
Petit Mal Epilepsy 0.6%
Product Used For Unknown Indication 0.6%
Tremor 19.2%
Nausea 15.4%
Drug Interaction 11.5%
Parkinsonism 11.5%
Hypertensive Crisis 7.7%
Incorrect Drug Administration Rate 7.7%
Serotonin Syndrome 7.7%
Surgery 7.7%
White Blood Cell Count Decreased 7.7%
Muscular Weakness 3.8%